跳至主要内容
临床试验/TCTR20190308005
TCTR20190308005进行中(未招募)未知

Effect of Vitamin B addition to Lidocaine for Myofascial Trigger Point Injection in Neck and Upper Back Muscles

Thammasat University0 个研究点目标入组 58 人开始时间: 2019年3月8日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • 1. The patients with diagnosis as myofascial pain syndrome at neck and upper back by Travel and Simon criteria
  • 2. The symptom persist not more than 6 months
  • 3. 18-70 years old patients

排除标准

  • 1. The patients who had been treated with Trigger point injection or dry needling at neck and upper back in 1 month
  • 2. The patients who had undergone neck or shoulder surgery in 1 year
  • 3. The patients with diagnosis as Fibromyalgia
  • 4. The patients with diagnosis as Cervical radiculopathy or Myelopathy
  • 5. Take blood-thinning medications including warfarin (Coumadin), or diagnosis as bleeding tendency disorder
  • 6. History of Using Vitamin B in last 1 month
  • 7. The Patients with intellectual or communication disabilities
  • 8. Allergy to Lidocaine or Vitamin B

研究者

相似试验